The Incretin Space logo
The Incretin Space
Subscribe
  • The Incretin Space
  • Topics
  • GIP

GIP

The master conductor

GLP-1TirzepatideGlucagonBimagrumabGIPSemaglutideAmylinRetatrutide
GLP-1GLP-1
+5+5
GLP-1 and the kidneys
Dec 16, 2025

GLP-1 and the kidneys

Incretins are changing the narrative of chronic kidney disease

GLP-1GLP-1
+3+3
First Retatrutide phase 3 data, a Triumph of Science!
Dec 11, 2025

First Retatrutide phase 3 data, a Triumph of Science!

Bariatric surgery in a shot! It might be too effective?! And what's dysesthesia?

GLP-1GLP-1
+2+2
Obesity Week 2025 Medications
Nov 14, 2025

Obesity Week 2025 Medications

Orforglipron, HRS 9531, MET-097, Eloralintide and Mazdutide, OH MY!

GIPGIP
GIP: SURPASSing all expectations
Sep 29, 2025

GIP: SURPASSing all expectations

Part 3 of the GIP series, cardiac benefits of GIP and a deep dive of the remarkable SURPASS CVOT trial results

GLP-1GLP-1
+1+1
GIP: The gentle & sensitive incretin
Sep 05, 2025

GIP: The gentle & sensitive incretin

Less nausea, more insulin sensitivity, and a little less inflammation Part 2 in a series on GIP

GLP-1GLP-1
+2+2
GIP: The unsung incretin
Jul 29, 2025

GIP: The unsung incretin

The master incretin of the alpha and beta cell starts to shinePart 1 in a series on GIP

A collection of collated data on incretin drug developments, including new drugs, new treatments and the future of incretin in medicine

The Incretin Space

A collection of collated data on incretin drug developments, including new drugs, new treatments and the future of incretin in medicine

Home

Posts

© 2025 The Incretin Space.

Privacy policy

Terms of use

Powered by beehiiv